|
健保碼及健保價 |
|
See related Monoclate-P powd for inj[人體血凝素第八因子 乾粉注射劑] information |
|
|
|
製造商 |
CSL Behring |
|
成份 |
Factor VIII
Click to view factor viii information |
|
適應症及用量 |
For details on therapeutic uses and relevant dosage relating to the factor viii ... Click to view factor viii |
|
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
劑型/包裝 |
|
劑型 |
包裝 |
圖片 |
|
Monoclate-P 乾粉注射劑 |
|
Monoclate-P 100 IU/1 mL x 1's |
|
|
|
Manufacturer: |
CSL Behring |
|
|
|
|
|
